CANNACTIVE
DEAD

Serial Number

88425687

Owner

Aphria Inc.

Attorney

Courtney Thompson

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CANNACTIVE Trademark

Serial Number: 88425687

CANNACTIVE is a trademark filed by Aphria Inc. on May 10, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 31 (Natural Agricultural Products), Class 32 (Light Beverages), Class 34 (Smokers Articles). The application is currently no longer active.

Owner Contact Info

Aphria Inc. (125 trademarks)

265 Talbot Street West
Leamington, Ontario N8H4H3 , CA

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

Not Registered

Goods & Services

Food products containing hemp and derivatives thereof, namely, chocolates, cookies, brownies, candy and granola-based, cereal based food energy bars; tea, namely teas containing hemp and derivatives thereof; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Bath additives, namely, cosmetic bath salts, bath melts, bath herbs, bubble bath, foam bath, bath bombs, bath gel, bath beads, bath flakes, bath crystals; non-medicated lip care preparations, non-medicated lip conditioners, liquid soaps, namely, non-medicated bath soaps, non-medicated liquid soaps, liquid soaps for laundry; non-medicated skin care preparations; bath oils; bath oils for cosmetic purposes; beauty care cosmetics; beauty creams for body care; beauty gels; beauty lotions; body and beauty care cosmetics; body creams; cosmetic body oils; cosmetic creams; cosmetic oils; cosmetics and make-up; face and body lotions; face and body milk; face lotion; hair care preparations; hair styling preparations; hand cream; hand lotions; non-medicated lip care preparations; non-medicated lip conditioners; lip glosses; massage creams; massage oils; non-medicated bubble bath preparations; non-medicated preparations for the care of hair; non-medicated preparations for the care of skin; non-medicated preparations for the care of the scalp; oils for toiletry purposes; skin creams; skin emollients; skin lotions; skin soap; non-medicated soaps for body care; non-medicated soaps for personal use, namely, cream soaps, bath soaps, bar soaps, paper soaps; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of liquids for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD or exclusively for use with goods having a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp, lighters for smokers

Smoothies, fruit beverages and fruit juices, carbonated soft drinks, and energy drinks each containing hemp and derivatives thereof; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD

Live hemp plants; all of the foregoing with a delta-9 THC concentration of not more than 0.3% dry weight basis

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 17, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 17, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 9, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 22, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 22, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 22, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 20, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 11, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 11, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jan 11, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 17, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 13, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 13, 2021 GNSL
SUSPENSION LETTER WRITTEN
Dec 13, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2021 CRFA
ASSIGNED TO LIE
Dec 6, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 2, 2021 ERSI
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 COAR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 8, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 8, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 8, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 18, 2020 GNSL
SUSPENSION LETTER WRITTEN
Nov 18, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 20, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 19, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 19, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 19, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2019 DOCK
ASSIGNED TO EXAMINER
May 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
NEW APPLICATION ENTERED
May 14, 2019 NWAP